The Brain-Heart Team Approach: Secondary Prevention After a Presumed PFO-Mediated Stroke

Overview

Join expert faculty at a SCAI-sponsored dinner satellite symposium at the International Stroke Conference in Dallas, February 8. Faculty will present a case-based discussion on the brain-heart team approach to possible treatment options for patients with cryptogenic stroke and PFO. ISC23 attendees and non-attendees are welcome to attend.

Registration is complimentary.

This event is not part of the official International Stroke Conference 2023 as planned by the International Stroke Conference Program Committee.

Faculty

	Megan Coylewright, MD, FSCAI Director, Structural Heart Program Erlanger Heart and Lung Institute Symposium Chair, Interventional Cardiology		Steven Messé, MD Professor of Neurology Hospital of the University of Pennsylvania Symposium Chair, Neurology
	Megan Stevens, MD Vascular Neurologist Erlanger Hospital University of Tennessee Chattanooga Affiliated Assistant Professor Department of Neurology		Molly Szerlip, MD, FSCAI Medical Director of the Percutaneous Valve Program Baylor Scott & White
	David E. Thaler, MD, PhD, FAHA Chairman, Department of Neurology Professor of Neurology Director emeritus, The Comprehensive Stroke Center Tufts University School of Medicine		John J. Volpi, MD Associate Professor of Clinical Neurology The Elkins Family Distinguished Centennial Clinical Academic Scholar in Neurology Houston Methodist

Program

Welcome & Introductions, Drs. Coylewright and Messé
Overview: Epidemiology and Burden of PFO-Associated Stroke, Dr. Volpi
State of the Evidence for PFO Closure, Dr. Thaler
Review of Current Practice Patterns, Dr. Messé
Structuralist’s View of the PFO, Dr. Szerlip
Building a Brain-Heart Team, Optimizing Patient Outcomes. A Tale of 3 Patients to Illustrate Our Team Goals, Drs. Coylewright and Stevens
Discussion

Learning Objectives

At the conclusion of this activity participants will be able to demonstrate the ability to:

Describe the epidemiology and burden of cryptogenic ischemic stroke
List competencies and resources necessary to constitute a Brain-Heart team
Perform the complete evaluation of ischemic stroke patients to determine stroke mechanism
Describe key clinical trial data regarding the safety and efficacy of FDA-approved devices for PFO closure to prevent secondary stroke
Suspect PFO in patients with cryptogenic stroke and ensure appropriate team-based evaluation
Deploy shared decision-making principles with cryptogenic stroke patients with PFO to determine the patients preferred secondary stroke prevention strategies

Acknowledgement of Commercial Support

This activity is supported through unrestricted educational grants from Abbott and W.L. Gore & Associates. No in-kind commercial support was received.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Attend the live activity and complete the evaluation to obtain credit.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered